| Names | |
|---|---|
| Preferred IUPAC name | N,N'-(benzene-1,4-diyl)bis(3-oxobutanamide) |
| Other names | AAAPhAA 1,4-Phenylene bisacetoacetamide 1,4-Bis(acetoacetamido)benzene |
| Pronunciation | /ɛn, ɛn ˌwʌn fɔːˈfiː.nɪliːnˌbiːs əˌsiːtəʊˌæsiːtəˈmæmɪd/ |
| Identifiers | |
| CAS Number | 15304-58-6 |
| 3D model (JSmol) | `3DModel:JSmol:Cc1cc(NC(=O)C(C)=O)ccc1NC(=O)C(C)=O` |
| Beilstein Reference | 113159 |
| ChEBI | CHEBI:134043 |
| ChEMBL | CHEMBL185118 |
| ChemSpider | 11687521 |
| DrugBank | DB07995 |
| ECHA InfoCard | 06e9f5a9-4cb6-4f35-b327-8fd069df2a8e |
| EC Number | EC 413-720-2 |
| Gmelin Reference | 95860 |
| KEGG | C21083 |
| MeSH | C16H16N2O4 |
| PubChem CID | 177478 |
| RTECS number | UF3850000 |
| UNII | 8AFE32A13Q |
| UN number | UN2811 |
| CompTox Dashboard (EPA) | DTXSID4011503 |
| Properties | |
| Chemical formula | C14H16N2O4 |
| Molar mass | 290.30 |
| Appearance | Light yellow powder |
| Odor | Odorless |
| Density | 1.27 g/cm³ |
| Solubility in water | Insoluble |
| log P | 1.01 |
| Acidity (pKa) | 10.5 |
| Basicity (pKb) | 8.9 |
| Magnetic susceptibility (χ) | -32.28 × 10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.621 |
| Viscosity | Viscosity: 37 mPa·s (20 °C, 20% in DMF) |
| Dipole moment | 3.61 Debye |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 367.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -726.7 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -1911.8 kJ/mol |
| Pharmacology | |
| ATC code | N02BG07 |
| Hazards | |
| Main hazards | H302 + H312 + H332: Harmful if swallowed, in contact with skin or if inhaled. |
| GHS labelling | GHS02, GHS07 |
| Pictograms | GHS07,GHS09 |
| Signal word | Warning |
| Hazard statements | H302, H315, H319, H335 |
| Precautionary statements | P264, P270, P280, P301+P312, P305+P351+P338, P330, P501 |
| NFPA 704 (fire diamond) | 1-1-0 |
| Flash point | > 301.1 °C |
| Lethal dose or concentration | LD50 Oral Rat 5000 mg/kg |
| LD50 (median dose) | LD50 (median dose): >2000 mg/kg (rat, oral) |
| NIOSH | Not listed |
| PEL (Permissible) | Not Established |
| REL (Recommended) | 20 mg/kg |
| Related compounds | |
| Related compounds | Acetoacetanilide N-Phenylacetamide 1,4-Phenylenediamine Isophthalamide Terephthalamide |
| Property | Description |
|---|---|
| Product Name & IUPAC Name | The industrial designation for this compound is N,N'-(1,4-Phenylene)bis(acetoacetamide). The IUPAC name reflects both the aromatic core and the acetoacetamide functionalization, which influence reactivity and formulation options for condensation or crosslinking downstream. |
| Chemical Formula | C14H16N2O4. This formula is affirmed by both analytical assay during release and by raw material balance in synthesis. Variations in molar composition signal possible impurity profiles or off-specification production, which triggers internal review protocols. |
| Synonyms & Trade Names | Synonyms encountered in technical correspondence and product requests: 1,4-Phenylenebis(acetoacetamide); N,N′-p-Phenylenebisacetoacetamide. Trade names are driven by downstream applications or regional distribution but do not factor into technical consistency or test standardization at our production facility. |
| HS Code & Customs Classification | In customs documentation and export declarations, most manufacturing facilities file this product under HS Code 2924.19 (Aromatic amides), unless a specific application or local authority ruling demands a finer categorization. Allocation to the correct HS code supports compliance with cross-border transit requirements and batch traceability during international logistics. |
| Aspect | Manufacturer Observation |
|---|---|
| Raw Material Selection | Consistency in the phenylenediamine core and acetoacetic acid derivatives directly influences final color, purity, and solubility profile. Raw materials are routinely screened for moisture content, particle size, and purity by in-house QC to minimize batches flagged for rework or deviation. |
| Process Route | Amide formation requires precise control of temperature and stoichiometry to reduce di-acylated byproduct levels. Scale-up triggers reassessment of mixing intensity, reaction seeding, and in-process pH adjustments. |
| Key Control Points | Monitoring of reaction progress by HPLC or FTIR assures intermediate consistency and supports early detection of impurity drift. Batch-to-batch reproducibility anchors on statistical process control using real-time analytic feedback. |
| Impurity Generation | Principal impurities stem from incomplete reaction, over-acylation, and mother liquor carryover during isolation. Liquid-liquid extraction and crystallization protocols are adjusted seasonally to optimize filtration rates and final product clarification. |
| Purification Strategy | Batch purification integrates solvent choice and temperature ramping customized per campaign. For specification-critical grades, the protocol involves activated carbon treatment and controlled cooling cycles. |
| Batch Consistency & Release Criteria | Analytical acceptance ranges for assay, moisture, and impurity levels are grade-dependent and set according to customer specification sheets or internal consensus limits based on historical QC data. Any batch showing atypical analytical signatures is subjected to additional review before release. |
| Property | Manufacturer Technical Commentary |
|---|---|
| Observed in Industrial Production | Typical production campaigns expose variation in particle size distribution, residual solvent content, and crystallinity, all of which influence flowability during downstream handling. Grade-specific adjustments to drying protocols are employed based on end-use. |
| Grade & Application Sensitivity | Required purity and physical form are driven by application: pigment intermediates demand different impurity control strategies compared to those meant for specialty resins. Packing solutions chosen match customer processing needs—bulk bagging for resin-makers or small packaging for research applications. |
| Impact on Storage & Handling | The presence of residual moisture or process-derived volatiles poses risk for caking or degradation in storage, demanding regular monitoring of packaging integrity for sensitive grades. Warehousing practices prioritize stable, dry environments with audit trails for post-release investigation. |
| Formulation and Downstream Processing | Suitability for reactive blending, cross-linking, or dispersion in customer operations depends on both the achieved purity and the physical form delivered. Feedback from end-users on behavior during application often guides adjustments to process control benchmarks in subsequent production campaigns. |
N,N'-(1,4-Phenylene)bis(acetoacetamide) commonly appears as a white to off-white crystalline solid in technical and fine chemical grades. The physical form—ranging from coarse granules to fine powder—depends on downstream isolation, milling, and sieving protocols. Odor is not usually pronounced under ambient storage, which aids in cleanroom and batch room controls. Melting point range increases with purity and decreases with crystalline defects introduced during rapid cooling or insufficient drying. The boiling point lies above standard laboratory distillation limits and is rarely assessed directly by manufacturers, as thermal decomposition may precede bulk boiling. Flash point assessment is not industry standard for this compound due to its thermal profile. Product density impacts packaging and solution dosing and varies subtly with particle size and residual solvent content.
The compound maintains chemical integrity if stored free from high humidity, prolonged light exposure, and aggressive acids or bases. Batch experience shows greatest sensitivity to hydrolysis under moist conditions, especially during extended storage. Residual solvent or entrained catalyst can sometimes accelerate degradation. End-users requiring long shelf life or high purity for synthesis applications should preferentially request freshly packed material.
Solubility characteristics are grade-dependent and highly sensitive to crystal habit and trace impurities. Most commercial samples dissolve in mid-polar organic solvents and show partial solubility in alcohols; purity and particle size influences the rate and completeness of solution formation. End-users targeting formulation or condensative coupling should validate solubility in each new batch, as both physical and chemical parameters influence it. As a manufacturer, we recommend preparing solutions using dry, filtered solvents and measuring for undissolved particulate prior to scale-up.
| Parameter | Technical/Industrial | Fine Chemical | Research |
|---|---|---|---|
| Appearance | White/Off-white solid | White, high purity | Variable, often as received |
| Purity (HPLC/GC) | Controlled per batch, application-dependent | Higher standard, tailored to downstream need | User-validated |
| Moisture (%) | Low range, dried before dispatch | Minimized, with COA available | Typical, not always specified |
Actual limits for impurities and by-products are established at batch release based on production route, customer needs, and region-specific requirements. Detailed specifications—such as allowable levels for acetoacetic acid, aniline, or trace metals—are disclosed on official batch COAs for regulatory and QA audits.
Primary impurities originate from incomplete reaction, side-product formation (including over-acylation, phenylene isomers, oligomers), and raw material variability. Downstream use in specialty synthesis or pharma markets invokes stricter specifications for color, heavy metals, and catalytic residues. Each production run undergoes chromatography and spectroscopic review, with quality limits tied to internal release norms and, where applicable, customer contractual limits.
Testing protocol selection depends on end-use: HPLC and GC are routine for purity; IR and NMR confirm structure and identify aromatic or diketone impurities. Moisture assessment typically uses Karl Fischer titration. Assessment standards conform to internal procedures, which adapt as needed to support customer audit demands or regulatory filings.
Raw material selection focuses on minimizing cost and process impurities, as small fluctuations in 1,4-phenylenediamine or diketene sources influence overall impurity levels and color grades. Sourcing contracts require documentation for trace contaminants and batch traceability, especially for pharma and electronics applications.
Manufacture employs a condensation reaction between 1,4-phenylenediamine and acetoacetic ester derivatives or diketene, under controlled pH and temperature. Batch or semi-continuous operation is chosen based on required throughput, impurity control, and operator safety. Route selection balances cost of raw materials, yield, and downstream purification challenges.
Reaction conditions—such as temperature, pH, solvent use, and addition rates—are tightly controlled to minimize by-product formation and maximize conversion. Key control points include monitoring endpoint by HPLC, managing batch temperature ramp to reduce undesired polymerization, and staged filtration/crystallization to separate product from soluble impurities. Purification strategy often involves multistep recrystallization; solvent selection depends on grade required, cost, and ease of residual removal.
Batch-to-batch consistency is maintained through process analytics, traceability logs, and full specification testing before release. Criteria are guided by customer contract, regulatory standards, and plant history. Out-of-spec batches trigger root cause investigation and, if feasible, reprocessing.
N,N'-(1,4-Phenylene)bis(acetoacetamide) serves as an intermediate in Knoevenagel and Michael-type polymerizations, facilitates cross-couplings, and reacts with isocyanates or aldehydes for specialty resin synthesis. The two acetoacetamide groups provide reactive sites, making batch-to-batch consistency significant for these downstream applications.
Optimal conditions for downstream transformations—such as base, temperature, or solvent composition—must be adjusted based on actual impurity and moisture profile in the supplied batch, as even minor contaminants affect reaction course and yield. Customers requiring particularly high reactivity or targeting complex derivatives should test each batch under their process conditions.
This compound forms a starting point for synthesizing specialty dyes, resins, and crosslinking agents. Potential for functional modifications exists on both the aromatic core and the diketone groups; grade and purity required depend on the chemistry planned and the tolerance to trace process residues.
Products store best in tightly sealed, opaque containers at moderate temperatures. Direct sunlight, excess heat, and atmospheric moisture drive hydrolysis and color degradation rates upward. For high-purity or pharmaceutical grades, nitrogen-purged packaging remains standard to mitigate oxidative changes. Storage recommendations are tailored to plant logistics, regulatory models, and expected turnover intervals.
Compatible packaging includes HDPE, glass, or lined metal containers not prone to solvent leaching or catalyzing degradation. Selection aligns with class of product and market (technical, fine, or pharma).
Shelf life outcome depends most strongly on moisture ingress, batch process by-products, and packaging integrity. Typical visual changes before functional loss include color darkening and caking. Formal shelf life claims are batch- and use-case-specific and are issued only after stability testing under agreed conditions.
Hazard classification varies with regulatory region and actual impurity spectrum. Most industrial and laboratory protocols advise treating as a potential irritant with possible sensitization risk. Specific GHS labeling depends on analytical test results per batch.
Manufacturing practice and downstream handling both emphasize use of gloves, dust masks, and eye protection to prevent dermal and respiratory exposure. Spillage on damp surfaces increases hydrolysis and potential for skin irritation. Local ventilation and proper containment reduce workplace incidents.
Limited direct mammalian toxicity data exists. Practically, the compound’s aromatic amide backbone necessitates careful exposure management, especially in open handling or high throughput compounding. In our manufacturing experience, tightly enforced hygiene and batch tracking limit potential issues associated with chronic or accidental exposure.
Permitted exposure limits remain unspecified for this specific entity; default plant hygiene and local authority guidelines dictate protocol. Handling guidance prioritizes dust minimization, chemical hygiene, and avoidance of accidental ingestion or prolonged skin contact.
We maintain dedicated batch lines for the synthesis of N,N'-(1,4-Phenylene)bis(acetoacetamide). Plant availability depends on the season, upstream supply of key intermediates, and maintenance shutdowns. When capacity planning for multi-ton production, disruptions often trace back to shortages in 1,4-phenylenediamine or diketene. Increased allocation usually follows quarterly demand forecasts, with adjustments in response to major project requirements from agrochemical and specialty coatings segments. For non-standard grades, extended QA release and longer cleaning validation may affect immediate capacity.
Typical lead times run two to four weeks for standard grades, assuming available slots on campaign schedule. MOQ varies by packaging, most frequently starting at one drum for industrial users but increasing for export-packed lots. For custom spec development or applications in regulated sectors, lead time expands to accommodate analytical transfer and QA validation protocols. Scheduling preference is given to contracted supply over spot transactions during high-utilization periods.
We provide packaging in fiber drums, HDPE drums, or lined cardboard, specified by grade and customer requirements. Moisture-barrier packaging is used for higher purity and analytical grades. Bulk packs in supersacks or ISO-containers are possible for large-scale formulation plants, subject to prior compatibility testing. Custom labeling, COA batch linkage, and regulatory-compliant documentation are standard.
Domestic shipments are organized on FCA or EXW terms. Export orders typically ship FOB from the nearest major port, with DAP/DDP for qualified longstanding partners. High-purity and regulated-market shipments involve documented temperature/climate control during transit. Payment usually proceeds on net 30, net 60, or per customer-negotiated contract; LC terms become mandatory on risk-monitored destinations.
Pricing closely shadows trends in 1,4-phenylenediamine, diketene, and solvents. These feedstocks account for the majority of RM input. Price movements arise from supply swings in coal-tar derivatives and acetoacetyl chloride, especially in China and India. Utility costs (steam, water, chilled brine) and labor contribute to OPEX but less to marginal price shifts unless regional energy spikes occur.
Feedstock interruptions, export curbs, or run-rate reductions at chemical parks directly affect cost base. Sudden surges may follow regulatory crackdowns in main producing regions, such as environmental shutdowns impacting phenylenediamine units. Process route changes (acetylation vs. acetoacetylation) at industrial scale occasionally trigger step-changes in material benchmarks.
Tiered pricing reflects analytical grade, industrial grade, and custom spec requests. Higher purities command significant differential, driven by extra purification (recrystallization, column treatment) and more stringent QA release. Packaging influences landed price: tamper-evident, pharma GMP-compliant lots typically carry a handling surcharge compared to basic industrial trade packs. Certificates (ISO, GMP, kosher/halal) drive up internal QA costs, reflected on premium lines.
Demand volume anchors in coatings, plastics additives, and selected pharmaceutical intermediates. China, India, the US, and Germany have concentrated downstream processing capacities. Sudden demand jumps track with new downstream launches, particularly in crop protection or specialty resins, but sharp corrections follow major plant turnarounds or site consolidations.
Pricing into 2026 faces upward potential from ongoing upstream environmental enforcement, especially in China and parts of India. New downstream applications may push segment-specific demand (e.g., specialty additives, non-polyurethane dispersants), but overhang from plant restarts will periodically dampen spot spikes. Currency fluctuations, energy cost volatility, and evolving compliance requirements will drive periodic upward corrections, especially on premium-certified grades.
Analysis draws from internal plant cost tracking, live procurement panels, major industry association briefings, and direct customer feedback. Quarterly reviews benchmark against market analytics platforms and peer manufacturer data, prioritizing upstream disruption signals and downstream order volatility.
Recent adjustments in Chinese and Indian feedstock policy have shifted synthetic economics for both intermediates and finished N,N'-(1,4-Phenylene)bis(acetoacetamide). Several large downstream buyers announced expanded contract frameworks through 2026, signaling interest in diversified supplier bases. Upgrades at regional chemical clusters in Southeast Asia continue, but full operational reliability remains to be validated.
REACH and TSCA registration continues as a primary focus for manufacturing protocols, with ongoing updates on analytical documentation and impurity reporting. Implementation of electronic batch tracking and transparent supply chain certification have become standard for pharma and food-applicable grades. New labeling rules and transport handling codes for European-bound product drive internal process and documentation reviews.
Increased QA resourcing and contingency raw material contracts address periodic volatility. Predictive maintenance and statistical process control have been deepened to cut batch failure and release lead times. Dual-sourcing and process route flexibility play primary roles in responding to regulatory tightening and logistics unpredictability. Long-term contracts and joint analytical method harmonization with key customers have mitigated price shock exposure for critical segments.
N,N'-(1,4-Phenylene)bis(acetoacetamide) serves as a key intermediate in several downstream sectors. Large-scale users predominantly operate in pigment and dye synthesis, resin modification, specialty polymer formulation, and certain pharmaceutical preprocessing stages. In pigment and resin work, the compound supports dye coupling and crosslinking due to its bifunctional structure. Performance in these fields varies with grade, especially when color stability or polymer compatibility is critical. In pharmaceutical scenarios, discussions with quality assurance teams frequently center on trace impurities and how reactor setup influences residual profiles.
From our quality audits and feedback cycles, observed application-specific differences often relate to purity and contaminant tolerances—buyers in pigments focus more on batch color consistency, while resin processors evaluate dispersibility. For pharmaceutical development, even minor lot-to-lot variation in impurity fingerprint causes delays in method validation and regulatory submissions.
| Application | Recommended Grade | Selection Rationale | Grade-Dependent Properties |
|---|---|---|---|
| Pigment/Dye Synthesis | Technical/Industrial | Emphasis on reproducible batch tone, manageable trace residuals. | Color index, residual aromatics, batch-to-batch tone uniformity. |
| Polymer/Resin Modifier | Pure/Technical | Polymerization compatibility driven by ash, volatility, solubility. | Ash content, melting profile, solubility in target media. |
| Pharmaceutical Intermediate | High/Pharma | Requires formal impurity profiling, validated trace control. | Low metal, organics, high reproducibility on assay, well-mapped impurity profile. |
In pigment and dye manufacture, visual and instrument checks on hue and intensity govern acceptance decisions. Deviations in residual starting amines impact color stability especially after storage. For resin and polymer partners, primary concern falls on melting behavior and compatibility with existing polymer matrices; high levels of ash or variable melting points complicate downstream curing or processing. Pharmaceutical purchasers often set upper limits on both inorganic salts and process byproducts, with release only triggered by batch-specific impurity maps and trend analysis over multiple lots.
Clarify core end use and prioritize main property targets. Pigment applications value color consistency, resin customers seek chemical and thermal stability, pharmaceutical teams mandate impurity mapping and test result repeatability. Direct lines with technical teams on both sides cut lead time in narrowing grade options.
For any regulated application, gather relevant pharmacopeia, REACH, or regional environmental requirements early. These rules can alter supplier approval, batch documentation, or impurity acceptance. In unregulated segments, internal purchasing standards often determine minimum documentation.
Trace byproduct tolerances shift according to both application and final customer acceptance criteria. Bulk pigment clients accept broader impurity bands, provided the final technical properties remain within specification. Polymer and resin users may require mid-level purity grades, mainly if processability or dispersibility issues crop up. Pharmaceutical partners push for detailed impurity data and expect consistency across all released lots.
Technical and high-purity routes differ in throughput and per-kilogram cost. High-volume, lower-purity operations often receive favorable pricing on technical grades, provided quality targets align. High-purity batches entail longer cycle times, additional purification stages, and batch traceability, directly impacting both cost and lead time.
Best practice recommends direct sample trials before full-scale orders. This phase permits in-house testing for compatibility, quality assurance validation, and real-time monitoring of core product features. Our laboratory supports side-by-side comparison across grades where specification margins are tight. Adjustments to specification or batch size proceed only when both functional and compliance tests clear customer-side acceptance.
Raw material selection directly influences both impurity landscape and production window. We evaluate upstream sourcing for consistent assay and minimal trace metal content. Process route alignment—either batch or continuous, solvent or melt—is driven by end-market requirements. Batch records document reactor parameters, impurity checkpoints, and intermediate yield, especially critical in move from development to commercial scale.
Critical control points in purification include solvent removal techniques, temperature ramping protocols, and post-crystallization washing. Our in-process controls track both primary assay and trace byproducts throughout the reaction profile. Batch-to-batch consistency leverages both in-line analytics and final release specifications, with corrective action if internal control limits trigger deviation alarms.
Each grade reflects unique handling, testing, and packaging protocols. Technical grades occupy standard bulk packaging and ship upon meeting color and assay checks. High-purity grades pass through additional fine filtration, documented retesting, and tamper-evident packaging per pharmaceutical or specialty requirements, extending both turnaround time and documentary burden.
Release criteria focus on property ranges, impurity bands confirmed by validated analytical methods, and real-world homogeneity across the lot. Adjustments or retesting occur where batch-specific performance drifts outside historical norms or customer-agreed specification bands.
Quality assurance for N,N'-(1,4-Phenylene)bis(acetoacetamide) begins at the level of process design and raw material sourcing. Our manufacturing facility aligns with internationally recognized quality management frameworks. Certification status may include ISO 9001 and other system registrations demanded by customers or required by regional regulatory authorities. These certifications focus on batch traceability, in-process controls, and deviation management—elements that consistently impact repeatability in downstream chemical syntheses and specialty formulation.
All certifications undergo annual third-party audits. Throughout each production campaign, change control and equipment maintenance logic directly link with the core requirements of each audited standard. Detailed certification status and audit schedules are available on request and may vary country by country according to legal, regulatory, or end-use requirements.
Regulatory submissions for N,N'-(1,4-Phenylene)bis(acetoacetamide) may include registration dossiers, REACH compliance, or other authority notifications. Exact certification scope depends on product grade and application, including specialty applications with pharmaceutical, electronic, or agricultural relevance. End-use declarations and limitation statements reflect both purity and process control during manufacture. Detailed grade-specific compliance documents are provided for each lot or shipment by customer request or as required by industry regulation. Typical certifications address grade-specific impurity benchmarks and process route declarations, not just final assay values.
Each consignment of N,N'-(1,4-Phenylene)bis(acetoacetamide) is accompanied by a comprehensive documentation set prepared by our technical department. This may comprise Certificates of Analysis, detailed raw material lot traceability, and custom specification sheets. First-batch or qualification shipments usually require additional characterization reports such as NMR, IR, and chromatographic impurity profiles, with methodologies disclosed subject to confidentiality agreements. Regulatory and safety dossiers can be updated in line with international chemical notifications, supporting internal compliance audits for our direct customers. Access arrangements for historical batch records follow both customer requirements and local regulatory mandates. Batch records maintain information on blend uniformity, in-process parameters, and deviations recorded during manufacture and packaging.
Experienced procurement departments recognize that consistency in supply of N,N'-(1,4-Phenylene)bis(acetoacetamide) often determines downstream plant efficiency. Core manufacturing capacity is defined based on installed reactor volume, cycle times, process batch size, and critical raw material lead times. We operate our production lines to support both fixed scheduling for long-term contacts and quick-reactivation modes suited to fluctuating short-cycle demand. Adaptation for customer safety stock requirements and production surpluses can be arranged through annual planning or flexible call-off schedules.
Business cooperation does not remain static. We have supported both one-off specialty campaigns and multiyear supply contracts. Order quantities, documentation formats, delivery frequencies, and packaging can be adjusted to reflect customer needs, changes in end-market volumes, or regulatory shifts. Confidentiality commitments and exclusivity clauses are negotiable where market position, patent filings, or licensing situations require bespoke handling arrangements.
Reliable delivery requires controlled batch size, tight lead time management, and redundant supply chain channels for key raw materials. We maintain buffer inventories at both raw material and finished goods stages, scaling batch production according to demand forecasts and customer forecasts. Production uses both single-lot and campaign-scale synthesis depending on grade and market demand. For grades with stringent impurity or low bioburden requirements, process capacity is adjusted downward to ensure tighter in-process specification control and enable downstream qualification or validation activities.
Our plant’s annual output capacity and warehouse throughput rates vary based on technical grade and customer commitments. For customers developing new applications or scaling up formulations, we provide technical support to evaluate likely demand fluctuations and recommend suitable capacity reservation strategies. Emergency supply agreements can be arranged contingent on upstream material availability and regulatory import/export timelines.
Initial sample requests for N,N'-(1,4-Phenylene)bis(acetoacetamide) are routed through our technical service team, requiring customer identification, intended application, desired quantity, and packaging preferences. Pre-shipment technical review with the customer enables grade matching and impurity or particle size optimization where needed. Regulatory and safety declarations for customer-specific uses, including toxicological and transport classification, can be appended to the sample dossier. Lead times for samples may depend on batch campaign scheduling or need for custom grade preparation, particularly for applications with non-standard purity, residue, or stabilizer requirements.
Feedback from sample evaluation flows directly to both technical production and quality control for continuous process adjustment. Scale-up samples or supplementary test quantities can be expedited if initial test results warrant re-optimization.
Industrial supply chains for specialty chemicals experience changes due to customer schedule shifts, regulatory actions, or feedstock disruptions. Flexibility in cooperation can take forms such as consignment inventory, rolling monthly forecasts, just-in-time lot releases, and call-off orders. For projects with regulatory, IP, or import/export sensitivities, dedicated production slots and confidential handling routines enable secure, transparent flows from manufacture to delivery. Consignment and on-site stock management for key accounts help reduce production downtime and support inventory optimization at the customer’s facility.
All flexible cooperation proposals originate from technical, logistic, and commercial team alignment, ensuring that each agreed-upon business model respects both quality compliance and the site’s operational discipline. The relationship adjusts depending on whether the customer is at early-stage R&D, commercial ramp-up, or market-mature phases, with written protocols to manage periodic review and property re-qualification as specifications evolve.
Current industrial R&D around N,N'-(1,4-Phenylene)bis(acetoacetamide) focuses on improving purity and consistency for downstream applications in polymer modification, specialty coatings, and advanced crosslinking agents. Large end-use segments demand grades with tailored particle morphology and minimized residual solvents, both highly sensitive to synthesis route and purification stage. Development teams are diving deep into process parameter optimization, targeting reduction of batch-to-batch color variation and limiting generation of trace byproducts correlated with specific raw material lots.
Functional materials sectors are evaluating this molecule for potential in high-temperature polymer stabilizers, active pharmaceutical intermediates, and electroactive polymers. Application teams in industrial labs report strong interest in exploiting its amide-acetoacetate motif for novel chelation and catalysis platforms. Interest comes from market pressures to phase out legacy crosslinkers with unfavorable health or regulatory profiles. Utilization in lithium-ion battery additives and specialty adhesives is increasing, where end-use volatility necessitates tighter control over residual moisture and insoluble trace organics.
Main challenges relate to process scalability, particularly during purification after condensation synthesis; reactive impurities must be controlled below application-dependent thresholds. Analytical development now enables faster verification of critical impurity profiles, supporting rapid process adjustments. Inconsistent intermediate stability and variable loss on drying remain key pain points, prompting investment in closed-system handling and controlled drying protocols. Among recent breakthroughs, refined process steps now offer routes to grades with improved solubility and dispersibility profiles—crucial for formulators seeking stable solutions at higher loading levels.
Market demand is expected to show steady growth in Asia and North America, driven by investments in performance polymers, aerospace composites, and eco-friendly paint formulations. Specialty chemical customers in Europe signal a shift toward greener synthesis routes and higher value-added performance ingredients, tightening purity thresholds and emphasizing verified supply chain traceability. Proprietary production routes that shorten the step count and reduce energy input are expected to start reshaping procurement specifications in the coming years.
Technical evolution in this segment is moving from basic batchwise operations to more modular and semi-continuous production systems. Inline process analytics for color, particle size, and residual solvent content allow for finer control during scale-up and commercial campaign manufacturing. Synthesis routes using alternative, less hazardous acylating agents are under pilot evaluation. Process engineers expect future plant upgrades to emphasize digital traceability and automated in-process specification checks for properties like particle dispersibility and amide integrity, which are directly tied to end-use performance in waterborne and high-solid systems.
For sustainability, raw material teams increasingly prioritize renewable feedstocks and seek to reduce reliance on petrochemical intermediates wherever feasible. Production teams face regulatory and customer pressure to minimize solvent emission and optimize process water re-use. Where region-specific requirements apply, production routes are adjusted to comply with stricter environmental standards, sometimes trading off yield in favor of reduced waste output. R&D labs participate in consortia to develop lower-emission synthesis protocols, benchmarking next-generation solvents and recyclable catalyst systems to meet evolving sustainability metrics.
Technical support teams offer direct consultation on raw material compatibility, solubility behavior across formulary solvent systems, and identification of root causes for unexpected residue or color issues arising during final product application. These challenges often trace back to grade-dependent differences in impurity spectrum or lot-to-lot variability linked to specific synthesis campaigns. Application scientists provide guidance on optimal handling and storage practices to prevent degradation under ambient or elevated humidity scenarios.
Engineers assist with tuning process steps such as dissolution protocols, order of addition, and temperature profiles for batch or continuous operations. Support extends to diagnostic troubleshooting for scaling challenges, interaction with common plasticizers or crosslinkers, and customized advice on adapting purification strategies to achieve tighter purity target windows. Technical input may cover particle dispersibility tuning and moisture exclusion recommendations, depending on downstream integration requirements. Samples can be supplied in multiple grades for method validation and side-by-side process benchmarks.
Commitments cover traceability from raw materials through to each shipment lot. Every outbound batch must meet final release standards defined through collaborative quality agreements with customers—these hinge on analytical data for color, residual solvent, and specified impurity classes. Feedback mechanisms route customer-reported technical issues directly to plant and quality teams, with response protocols designed for rapid root cause analysis and corrective action implementation. Documentation, such as Certificates of Analysis and full trace impurity spectra, support both post-delivery investigations and regulatory compliance requirements.
Manufacturing N,N'-(1,4-Phenylene)bis(acetoacetamide) in-house brings more than just cost advantages. Every batch stems from controlled process conditions starting with selected raw materials, closely monitored temperature profiles, and precision in reaction times. Process engineers do not release material until it meets critical performance ranges for purity and moisture. Our team oversees synthesis, filtration, and drying within a closed system. This manufacturing control reduces contaminants and offers a reliable supply for repeat buyers who measure trace consistency in large-scale applications.
N,N'-(1,4-Phenylene)bis(acetoacetamide) sees use across pigments, dyes, and specialty polymer chemistry. Colorants rely on this intermediate for stable hues and improved lightfastness. Adhesive and resin formulators specify this compound for crosslinking and enhanced durability. Waterborne coating systems integrate it to achieve end-use chemistry that remains robust under thermal stress. The compound’s performance has translated into adoption by formulators seeking greater shelf life and predictable batch-to-batch results.
Lab testing runs alongside production, with QC professionals inspecting every lot for main assay, appearance, particle profile, and end-use reactivity. Each lot receives a unique batch number, and historical QC data can be retrieved quickly for traceability. Screens for key impurities—including residual starting material and by-products—run as standard in our workflow. No shipment leaves without a certificate meeting specifications agreed with technical and purchasing teams.
Bulk customers often request drum or lined-bag packaging, and palletized volume shipments keep freight operations predictable for commercial schedules. Warehouse capacity supports JIT delivery for plant fill or buffer stock. We maintain buffer stocks to absorb fluctuations in downstream production for our established partners, reducing the risk of overstock or costly shutdowns at end-user facilities. Container quality prevents moisture ingress and provides stability during overseas shipping as well as regional transit.
End users benefit from technical exchange directly with our process chemists and QC specialists. Application support includes scale-up troubleshooting and formulation compatibility. Complex project requirements receive input at the bench level, backed by records of historical performance at plant scale. Our team has resolved questions around dissolving rates, filtration, and downstream compatibilities for numerous industries.
Direct communication and production minimize the gaps in understanding often found in third-party or trading channels. Our partners experience lower product transition risk, greater predictability for downstream R&D, and reduced administrative redundancy. Customers with audit requirements and supplier qualification protocols receive full traceability. Procurement teams reduce lead-time variability and improve supply chain resilience by working with a producer that owns chemistry, inventory, and packing lines.
Direct manufacturing of N,N'-(1,4-Phenylene)bis(acetoacetamide) underpins long-term supply agreements with performance-driven companies. By aligning our production with true customer requirements, we enable secure sourcing, documented reliability, and straightforward collaboration across the product lifecycle.
Producing N,N'-(1,4-Phenylene)bis(acetoacetamide) demands careful control over purity. Consistency in raw material sourcing and equipment settings plays a big role in achieving our standard purity grades, typically exceeding 98%. Customers in pigments, crosslinking agents, and specialty resins rely on this high threshold to keep downstream reactions free of side products. We use HPLC and elemental analysis throughout our process so clients can avoid batch-to-batch surprises. Any impurity, even at trace level, tends to impact color properties or reaction efficiency in finished applications.
In our manufacturing facilities, monitoring the melting point of each batch is part of routine QC. For N,N'-(1,4-Phenylene)bis(acetoacetamide), our typical melting point range falls between 226°C and 230°C based on repeated test results. This parameter signals whether the expected molecular structure has formed, showing no undesired isomers or byproducts. Deviations may hint at process variations or contamination, alerting our team immediately so we can adjust synthesis conditions or carry out additional purification steps. Downstream, our clients appreciate this because stable melting characteristics translate into predictable performance during compounding or further synthesis.
One property our clients always focus on: Solubility profile. In practice, N,N'-(1,4-Phenylene)bis(acetoacetamide) shows excellent solubility in polar organic solvents like dimethylformamide (DMF), dimethyl sulfoxide (DMSO), and N-methyl-2-pyrrolidone (NMP). Its moderate solubility in alcohols works well for resin and pigment formulators looking for flexibility. In water, solubility remains quite limited, which often benefits those targeting controlled-release or low-leaching characteristics. The compound’s balanced solubility opens doors for custom formulations, and our technical team has supported successful integration into unique solvent systems across different industries.
Quality starts at the reactor and flows through drying, milling, and final packaging. Each physical attribute—particle size, bulk density, flowability—tells us how the product will perform on customer production lines. Our in-process checks flag static or sticky product risks, and we optimize grind sizes for ease of handling, especially for extrusion or dispersion specialists. Finished batches pass through sieving and dust extraction so the delivered product meets both technical and safety expectations. This hands-on approach helps keep lines running without unexpected bottlenecks or downstream inconsistencies.
As a manufacturer, we see real-world challenges and help customers solve them daily. Example: clients in polymer additives sometimes request tighter moisture specification. Our atmospheric controls and additional drying steps address this directly. Strict traceability and batch records mean we can offer certificates of analysis for every lot. For custom projects, we work with partners to define particle size distributions or tailor solubility to specific solvents. Our technical support goes beyond the data sheet, bringing years of production experience to every application question. We invite feedback and keep lines of communication open—knowing our reputation grows with every successful formulation.
In chemical manufacturing, questions about minimum order quantity (MOQ), price per gram or kilogram, and lead time point toward what matters most for customers: security of supply, cost transparency, and production planning. As the direct manufacturer of N,N'-(1,4-Phenylene)bis(acetoacetamide), we know these details are just as important as technical specifications or material purity.
We face ongoing questions about minimum order sizes. Our own drivers here include batch processing efficiency, material sourcing, and downstream logistics. Handling orders at the gram scale adds real cost from extra packing and process interruptions. Factory-scale synthesis runs best in larger batches; for this compound, we set typical minimum orders at the multi-kilogram level. This allows our team to keep workflow smooth and pass on cost savings to customers who require higher volumes. For larger, ongoing projects, bulk supply agreements can improve cost per kilogram and lock down capacity ahead of project milestones.
Direct pricing per gram or kilogram emerges from raw material costs, production yield, labor, solvent recovery, QA/QC lab testing, and regulatory documentation. Quoting micro-quantities at a laboratory scale usually leads to higher prices per unit, because batch changeovers and handling time do not scale linearly. Most of our orders for N,N'-(1,4-Phenylene)bis(acetoacetamide) qualify for factory-direct pricing at kilogram scale, with tiered discounts offered for batch reservations above a certain threshold. Our sales and technical teams can break down these structures during project scoping to make budgeting forecasts more predictable. Pricing stability often comes from committing to blanket PO agreements or regular demand forecasts; such arrangements allow us to optimize our scale and feedstock procurement to pass through price benefits.
Honest timelines start on the shop floor. For this molecule, our production process runs to standard batch turnaround, but planning needs real numbers. Typical lead times for N,N'-(1,4-Phenylene)bis(acetoacetamide) at full-batch scale range from several weeks to just over a month, depending on order size and the complexity of the purification steps. Orders requiring custom purity or alternative packaging may extend the timeline slightly because of revalidation and lab controls. Demand spikes or shortages in upstream raw materials can introduce delays, but with early project visibility, our team can reserve production windows to keep shipment schedules firm. Shipping and export documentation are handled in-house, expediting clearance and reducing waiting time at destination ports.
Production bottlenecks stem from unforeseen surges in global demand for specialty amides or interruptions into intermediate supply chains. Keeping open communication with our customers allows for advanced forecasting and faster response strategies. We usually recommend placing blanket or forecasted orders for high-priority research or manufacturing projects. Batch reservation programs give customers peace of mind and reduce order lead time significantly during peak season or supply chain volatility.
As the active manufacturer, we go beyond meeting specifications by supporting customers with pragmatic order sizes, straightforward pricing, and clear production schedules. Engineers, procurement managers, and R&D coordinators can rely on us for regular updates throughout all stages of manufacturing and delivery, keeping projects on time and within budget.
As a chemical manufacturer deeply invested in the smooth, compliant delivery of specialty intermediates, we see regulations for shipping and international logistics fundamentally shaping how we move N,N'-(1,4-Phenylene)bis(acetoacetamide) from plant to customer. Every shipment leaves our facility with regulatory, safety, and documentation standards as a priority, not just as paperwork but as direct safeguards for handlers, end users, and the supply chain.
We classify and package each batch based on the material’s actual properties, referencing current national and international transport laws. For this compound, classification under the UN Model Regulations (ADR, IMDG, IATA) comes down to its physical and ecological profile; at present, N,N'-(1,4-Phenylene)bis(acetoacetamide) does not fall under hazardous goods classifications in many jurisdictions. Still, our experience tells us not to treat any specialty chemical as routine. Standard drum or carton packaging, clearly labeled, protects against moisture and cross-contamination.
Our logistics team maintains direct relationships with accredited carriers, ensuring that documentation—such as shipping labels and transport emergency cards—ride along with every consignment. If national law changes, our compliance team adjusts our shipment protocols and retrains our warehouse teams without delay. We never leave regulatory questions hanging—our technical and logistics departments work side by side to verify the correct loading and stacking methods before any consignment leaves our premises.
We prepare Safety Data Sheets according to GHS and the latest national adaptations, updating our templates whenever hazard data develops or regional regulations tighten. Our SDS provides in-depth safety, handling, storage, and environmental precautions for N,N'-(1,4-Phenylene)bis(acetoacetamide), tailored from real testing and risk management during manufacturing. Customers, carriers, and import authorities receive our SDS in the language and format they require.
Updates to SDS content are coordinated with our EHS and regulatory affairs staff. We issue a new revision immediately when there are changes in classification, exposure limit adjustments, or accident data comes to light. Consistency in documentation stands as a non-negotiable principle; our internal audits catch nonconformities before they reach a border checkpoint.
We keep customs and compliance officers’ needs in mind throughout the export process. Every order comes with a full pack of official documentation—commercial invoice, packing list, certificate of analysis from our own QA department, and any additional certificates needed for destination clearance. Our team coordinates with freight forwarders directly, not through third parties, tracking HS codes and ensuring that import permits or pre-shipment inspection instructions are followed strictly.
International buyers regularly request documentation to satisfy local authorities. We meet these requests with complete declarations and regulatory attestation reflecting our real-world process traceability and lot traceability records. As a manufacturer, we ensure declarations match up with production batch logs and analytical records, leaving nothing open to reinterpretation.
We do not wait for interruptions to force changes. We monitor legal amendments, ship trial quantities under new regimes before scaling, and always have a regulatory specialist review shipments headed for new destinations. This reduces the risk of detentions or returns, eliminates unnecessary repackaging, and protects all parties in the chain. The strength of our documentation—and the accuracy of our own manufacturing controls—provide reliability more than any generic compliance stamp ever can.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales7@bouling-chem.com, +8615371019725 or WhatsApp: +8615371019725
